Some recent applications of carbohydrates and their derivatives in the pharmaceutical industry

about

Some recent applications of carbohydrates and their derivatives in the pharmaceutical industry

Item

http://www.wikidata.org/entity/Q56680711

description

im Januar 1986 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в 1986

@uk

name

Some recent applications of ca ...... in the pharmaceutical industry

@en

Some recent applications of ca ...... in the pharmaceutical industry

@nl

type

Item

label

Some recent applications of ca ...... in the pharmaceutical industry

@en

Some recent applications of ca ...... in the pharmaceutical industry

@nl

prefLabel

Some recent applications of ca ...... in the pharmaceutical industry

@en

Some recent applications of ca ...... in the pharmaceutical industry

@nl

P1476

Some recent applications of ca ...... in the pharmaceutical industry

@en

P2093

C. A. A. van Boeckel

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma clearance of glycoproteins with terminal mannose and N-acetylglucosamine by liver non-parenchymal cells. Studies with beta-glucuronidase, N-acetyl-beta-D-glucosaminidase, ribonuclease B and agalacto-orosomucoid

Synthesis of the beta-adrenergic blocking agent timolol from optically active precursors

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates.

L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages

Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Stability of carbohydrate-modified vesicles in vivo: comparative effects of ceramide and cholesterol glycoconjugates.

Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).

Molecular requirements for B-lymphocyte activation by Escherichia coli lipopolysaccharide.

Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.

P304

35-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/RECL.19861050202

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

1986-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime